Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06308614 · ClinicalTrials.gov registry record · Phase 2
Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women
A Phase 2 study of Sexual Dysfunction, Physiological, sponsored by Estetra.
- Completed
- Registry status
- Phase 2
- Development phase
- 82
- Enrollment target
- 20
- Study locations
NCT06308614 is a Phase 2 study of Sexual Dysfunction, Physiological that has completed, run by Estetra. The registered enrollment target is 82 participants. The trial reports 20 study locations across 11 states.
The verdict
NCT06308614, a Phase 2 study of Sexual Dysfunction, Physiological, has completed, sponsored by Estetra.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 82 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this clinical trial is investigating estetrol (E4) in women after menopause, suffering from sexual arousal disorder. The main question it aims to answer is: is 20 mg estetrol monohydrate effective in the treatment of sexual arousal disorder in women after their menopause. Participants will visit the clinic 7 times and complete a daily diary while receiving estetrol or placebo for 12 weeks. Placebo is a pill that looks the same as estetrol but has no active ingredient. Researchers will compare estetrol and placebo to see if estetrol has an effect on the sexual arousal of the participants.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG 20 mg estetrol monohydrate
Study Locations (20)
Florida
- Estetra Study Site - Jacksonville
- Estetra Study Site - Miami
- Estetra Study Site - New Port Richey
- Estetra Study Site - Ocoee
- Estetra Study Site - Orlando
- Estetra Study Site - West Palm Beach
Arizona
- Estetra Study Site - Mesa
- Estetra Study Site - Phoenix
- Estetra Study Site - Tucson
California
- Estetra Study Site - Pomona
- Estetra Study Site - San Diego
Ohio
- Estetra Study Site - Cleveland
- Estetra Study Site - Englewood
Georgia
- Estetra Study Site - Atlanta
Illinois
- Estetra Study Site - Chicago
Nebraska
- Estetra Study Site - Omaha
Nevada
- Estetra Study Site - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2024-01-29 |
| Est. Completion | 2025-04-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06308614
The ClinicalTrials.gov registry entry for NCT06308614 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Estetra, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sexual Dysfunction, Physiological appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06308614 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT06308614 about?
NCT06308614 is a clinical study titled "Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women". The goal of this clinical trial is investigating estetrol (E4) in women after menopause, suffering from sexual arousal disorder. The main question it aims to answer is: is 20 mg estetrol monohydrate effective in the treatment of sexual arousal disorder in women after their menopause. Participants wi...
What is the current status of trial NCT06308614?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 82 participants. The study started on 2024-01-29. Estimated completion is 2025-04-21.
What conditions does trial NCT06308614 study?
This clinical trial studies the following conditions: Sexual Dysfunction, Physiological.
What interventions are being tested in trial NCT06308614?
The interventions under investigation include: Placebo (OTHER), 20 mg estetrol monohydrate (DRUG).
Who is sponsoring clinical trial NCT06308614?
This trial is sponsored by Estetra, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06308614 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexual Dysfunction, Physiological
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.